Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study

Title:	Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study
Authors:	Bigaut, Kévin^{Aff1, Aff2, Aff6, IDs00415021109507_cor1}; Kremer, Laurent^{Aff1, Aff2, Aff6}; Fabacher, Thibaut^Aff3; Ahle, Guido^Aff4; Goudot, Mathilde^Aff5; Fleury, Marie^{Aff1, Aff6}; Gaultier, Claude^Aff4; Courtois, Sylvie^Aff5; Collongues, Nicolas^{Aff1, Aff2, Aff6}; de Seze, Jérôme^{Aff1, Aff2, Aff6}
Source:	Journal of Neurology. 269(6):3295-3300
Database:	Springer Nature Journals